Skip to main content

Table 4 Odds ratios for the clinical and laboratory variables impacting pCR in a multivariable model

From: Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy – the SpheroNEO study

Characteristics

Odds ratio

95 % CI

P

Cell survival cutoff (>35 %/≤ 35 %)

0.011

0.001 – 0.096

.0001

Treatment adherence (no/yes)

0.115

0.014 – 0.925

.0421

HR status (pos/neg)

0.513

0.180 – 1.465

.2123

HER2 status (neg/pos)

0.167

0.050 – 0.560

.0037

Age (>50/≤50 years)

0.501

0.177 – 1.417

.1505